GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dimed SA Distribuidora de Medicamentos (BSP:PNVL3) » Definitions » Revenue

Dimed Distribuidora de Medicamentos (BSP:PNVL3) Revenue : R$4,660 Mil (TTM As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Dimed Distribuidora de Medicamentos Revenue?

Dimed Distribuidora de Medicamentos's revenue for the three months ended in Mar. 2024 was R$1,226 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was R$4,660 Mil. Dimed Distribuidora de Medicamentos's Revenue per Share for the three months ended in Mar. 2024 was R$8.24. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was R$31.46.

Good Sign:

Dimed SA Distribuidora de Medicamentos has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Dimed Distribuidora de Medicamentos was 14.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 17.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 28.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Dimed Distribuidora de Medicamentos's highest 3-Year average Revenue per Share Growth Rate was 750.10% per year. The lowest was -89.10% per year. And the median was 12.10% per year.


Dimed Distribuidora de Medicamentos Revenue Historical Data

The historical data trend for Dimed Distribuidora de Medicamentos's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimed Distribuidora de Medicamentos Revenue Chart

Dimed Distribuidora de Medicamentos Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,724.68 2,819.11 3,225.41 3,990.48 4,461.02

Dimed Distribuidora de Medicamentos Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,027.41 1,081.38 1,130.15 1,222.08 1,226.10

Competitive Comparison of Dimed Distribuidora de Medicamentos's Revenue

For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dimed Distribuidora de Medicamentos's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's Revenue distribution charts can be found below:

* The bar in red indicates where Dimed Distribuidora de Medicamentos's Revenue falls into.



Dimed Distribuidora de Medicamentos Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$4,660 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dimed Distribuidora de Medicamentos  (BSP:PNVL3) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Dimed Distribuidora de Medicamentos Revenue Related Terms

Thank you for viewing the detailed overview of Dimed Distribuidora de Medicamentos's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Dimed Distribuidora de Medicamentos (BSP:PNVL3) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its segments are divided into Retail, Wholesale and Corporate. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. The Wholesale segment is the distributor of drugs in Brazil. The Corporate segment includes Wholesale and Retail, as well as the subsidiary Lifar. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.

Dimed Distribuidora de Medicamentos (BSP:PNVL3) Headlines

No Headlines